The Centre for Cancer seeks to significantly reduce the impact of cancer by working to better understand the biology of the disease in order to tailor treatments to its genetic and proteomic profile.

Priority Research Centre for

About us

The Priority Research Centre for Cancer aims to integrate basic science & clinical research bi-directionally, to facilitate rapid development and implementation of our research discoveries, and to stimulate lab research on priority questions generated from the clinic.

Supporting the translation of cancer research from bench-to-bedside and beyond, the local research supported by the Priority Research Centre for Cancer provides the foundations for the pursuit for personalised medicines.

Through a growing need to consolidate, collaborate and better communicate across the translational pipeline, the University's Cancer Priority Research Centre, together with three other Hunter New England-based research networks, has amalgamated under the umbrella organisation known as The Hunter Cancer Research Alliance (HCRA).

The support offered by this Centre aims to strengthen collaborations, improve communications and increase research output through coordinating cross-translational research activities, as well as provide direct financial support to early career researchers whom have been identified as leaders in their field.

The Centre provides a supportive and productive research environment for staff and research higher degree students, it includes biomedical, clinical and public health researchers working across integrated research groups, including cancer genetics, cellular and molecular oncology, anti-cancer therapies, cancer trials, psycho-oncology and health behaviours.

The Hunter Cancer Research Alliance, established in January 2012, is the umbrella organisation to the key cancer research programs operating throughout the Hunter New England region:

As a multidisciplinary and multi-institutional alliance, the HCRA brings together over 270 researchers and clinicians from the Hunter Medical Research Institute, the University of Newcastle, and Hunter New England Local Health District in partnership with Calvary Mater Hospital Newcastle .

The HCRA functions to provide capacity building, funding and strategic support to cancer research across the full research practice continuum; from basic research through clinical trials to behavioural; implementation and health services research. HCRA has two Flagship Programs that were formed in 2014 with the view that these research programs will assist HCRA in achieving their vision of establishing the Hunter New England as a competitive global hub of excellence in translational cancer research. The HCRA Flagship Programs are:

  1. Biomarkers and targeted therapy: Discovery, development and implementation
  2. Implementation science and evaluation of strategies designed to reduce the evidence practice gap